Literature DB >> 12828843

Studies of alpha-adrenoceptor antagonists on sympathetic mydriasis in rabbits.

Yongxin Yu1, Michael C Koss.   

Abstract

This study was undertaken to identify the alpha-adrenergic receptor type responsible for sympathetically evoked mydriasis in pentobarbital-anesthetized rabbits. Frequency-response curves of pupillary dilation were generated by stimulation of the preganglionic cervical sympathetic nerve (1-64 Hz). Evoked mydriatic responses were inhibited by systemic administration of nonselective alpha-adrenergic antagonists, phentolamine (0.3-10 mg/kg) and phenoxybenzamine (0.03-0.3 mg/kg), as well as the selective alpha(1)-adrenergic antagonist, prazosin (0.1-1 mg/kg). The alpha(2)-adrenergic antagonist, RS 79948 (0.3 mg/kg, i.v.) was without inhibitory effect, but potentiated the mydriatic response. In addition, the selective alpha(1A)-adrenoceptor antagonist, 5-methylurapidil (0.1-1 mg/kg, i.v.), antagonized the elicited mydriasis in a dose-dependent fashion. Unlike previous observations that prazosin does not block the adrenoceptor in rabbit iris dilator muscle, our results suggest that prazosin is effective in inhibiting neuronally elicited mydriasis in this species, and that alpha(1A)-adrenoceptors appear to mediate the response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828843     DOI: 10.1089/108076803321908374

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  10 in total

1.  In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Authors:  Martin C Michel; Hiroko Okutsu; Yukiko Noguchi; Masanori Suzuki; Akiyoshi Ohtake; Hironori Yuyama; Hiroko Yanai-Inamura; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Masao Sasamata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-18       Impact factor: 3.000

2.  Effect of tamsulosin on iris vasculature and morphology.

Authors:  Roni M Shtein; Munira T Hussain; Theresa M Cooney; Victor M Elner; Christopher T Hood
Journal:  J Cataract Refract Surg       Date:  2014-03-14       Impact factor: 3.351

3.  Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.

Authors:  Zuhair K Al-Hussaini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 4.  Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications.

Authors:  Daniel M Handzel; Sebastian Briesen; Steffen Rausch; Tilman Kälble
Journal:  Dtsch Arztebl Int       Date:  2012-05-25       Impact factor: 5.594

5.  Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatment.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

6.  Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.

Authors:  Tiago Santos Prata; Pat-Michael Palmiero; Allison Angelilli; Zaher Sbeity; Carlos Gustavo V De Moraes; Jeffrey M Liebmann; Robert Ritch
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

7.  Evaluation of Anterior Segment Changes of Patients Taking Alpha1-Blockers by Ultrasound Biomicroscopy in the Drug-free Period.

Authors:  Yeliz Acar; Kadir Eltutar; Sibel Zırtıloğlu
Journal:  Turk J Ophthalmol       Date:  2017-08-15

8.  Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases.

Authors:  Ya-Hui Wang; Liang-Chen Huang; Sung Huang Laurent Tsai; Ying-Jen Chen; Chien-Liang Wu; Yi-No Kang
Journal:  Front Med (Lausanne)       Date:  2022-08-30

Review 9.  Intraoperative Floppy Iris Syndrome Induced by Tamsulosin: The Risk and Preventive Strategies.

Authors:  Mansour Tobaiqy; Waseem Aalam; David Banji; Ekram N Abd Al Haleem
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

10.  Modulation of physiological reflexes by pain: role of the locus coeruleus.

Authors:  Elemer Szabadi
Journal:  Front Integr Neurosci       Date:  2012-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.